AOD9604 Spray

AOD9604 5mg Spray is a research-grade synthetic peptide solution developed for laboratory investigations involving lipid metabolism, adrenergic receptor signaling, and non-invasive delivery methods. Chemically classified as a cyclic analog of human Growth Hormone C-terminus fragment 177-191, it comprises 16 amino acid residues with the sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe, containing an intramolecular disulfide bridge between Cys7 and Cys14. As an investigational compound, AOD9604 is studied for its ability to selectively stimulate lipolysis without triggering somatotropic growth cascades.

From a molecular research perspective, AOD9604 Spray provides a valuable model for investigating the transport kinetics of cyclic oligopeptides across epithelial cell layers. Standard fat metabolism studies frequently depend on parenteral routes; however, liquid spray preparations enable researchers to evaluate how medium-sized cyclic peptides cross mucosal membranes, interact with tight junctions, and engage localized cellular receptors. This spray format is particularly suited for research involving nasal mucosal cell lines.

Current laboratory investigations examine AOD9604's mechanism of action on adipocytes. The peptide targets pathways regulating lipid breakdown (lipolysis) and lipid accumulation (lipogenesis). Studies evaluate how AOD9604 stimulates beta-3 adrenergic receptor pathways in adipose tissue, increasing intracellular cAMP and activating hormone-sensitive lipase (HSL) to drive fatty acid beta-oxidation. Simultaneously, it is investigated for its ability to inhibit acetyl-CoA carboxylase and other lipogenic enzymes, suppressing lipid droplet accumulation.

Crucially, researchers use AOD9604 to explore non-somatotropic growth hormone signaling pathways. Unlike full-length growth hormone, AOD9604 does not bind to the growth hormone receptor (GHR) due to the absence of the N-terminal receptor binding domains. Consequently, exposure to AOD9604 does not stimulate insulin-like growth factor-1 (IGF-1) secretion, preventing cellular proliferation (mitogenesis), glucose intolerance, and tissue hyperplasia associated with exogenous growth hormone administration.

In tissue engineering and regenerative medicine research, AOD9604 is also investigated for its capacity to support chondrocyte differentiation and cartilage matrix deposition. The liquid spray format provides an optimized experimental model for studying direct mucosal absorption and localized tissue kinetics. Researchers evaluate whether mucosal delivery or local spray administration facilitates transport to target adipose or articular cartilage structures without systemic variables.

Each bottle of AOD9604 Spray is manufactured using solid-phase peptide synthesis (SPPS), followed by disulfide bridge cyclization, purification, and solution formulation steps. The resulting active peptide is dissolved in a stabilized, buffered aqueous solution calibrated to ensure exact concentration per metered spray activation. Quality control protocols include reverse-phase HPLC for purity verification and LC-MS for molecular identity confirmation.

To preserve the stability of the peptide in solution, AOD9604 Spray should be stored under refrigeration (2°C to 8°C) and protected from light. Because cyclic disulfide peptides can undergo slow oxidation, disulfide exchange, or peptide cleavage in aqueous environments over time, maintaining refrigerated storage and minimizing atmospheric exposure is critical to preserving peptide integrity. Proper handling supports consistent concentration and analytical reproducibility across laboratory protocols.

Scientific interest in AOD9604 continues to expand as researchers seek to characterize its stability, beta-3 adrenergic interactions, and transport kinetics. Nevertheless, many aspects of its cellular signaling and epithelial transport remain active areas of scientific inquiry. Ongoing studies continue to refine the understanding of selective lipolytic peptides in biological systems. For this reason, AOD9604 Spray should be regarded as an investigational compound whose primary value lies in advancing scientific knowledge of metabolic receptor biology.

AOD9604 Spray is supplied exclusively for laboratory research and analytical applications. It is intended for Research Use Only (RUO) and is not approved for human consumption, therapeutic use, veterinary use, or diagnostic purposes.